Publications by Zalcberg, John

Journal article

Goey, Kaitlyn K. H.; Sorbye, Halfdan; Glimelius, Bengt; Adams, Richard A.; Andre, Thierry; Arnold, Dirk; Berlin, Jordan D.; Bodoky, Gyorgy; de Gramont, Aimery; Diaz-Rubio, Eduardo; Eng, Cathy; Falcone, Alfredo; Grothey, Axel; Heineman, Volker; Hochster, Howard S.; Kaplan, Richard S.; Kopetz, Scott; Labianca, Roberto; Lieu, Christopher H.; Meropol, Neal J.; Price, Timothy J.; Schilsky, Richard L.; Schmoll, Hans-Joachim; Shacham-Shmueli, Einat; Shi, Qian; Sobrero, Alberto F.; Souglakos, John; Cutsem, Eric van; Zalcberg, John; Oijen, Martijn G. H. van; Punt, Cornelis J. A.; Koopman, Miriam (2018): Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group. In: European Journal of Cancer, Vol. 100: pp. 35-45

Casali, Paolo G.; Zalcberg, John; Cesne, Axel le; Reichardt, Peter; Blay, Jean-Yves; Lindner, Lars H.; Judson, Ian R.; Schoffski, Patrick; Leyvraz, Serge; Italiano, Antoine; Grunwald, Viktor; Pousa, Antonio Lopez; Kotasek, Dusan; Sleijfer, Stefan; Kerst, Jan M.; Rutkowski, Piotr; Fumagalli, Elena; Hogendoorn, Pancras; Litiere, Saskia; Marreaud, Sandrine; Graaf, Winette van der; Gronchi, Alessandro; Verweij, Jaap (2017): Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels. In: Journal of Clinical Oncology, Vol. 35, No. 15: pp. 1713-1720